Tofacitinib Nitrosamine 1
✓
100 % de precisión de datos
Soporte científico 24/7
⬡
Tolerancia 0 % en la calidad del producto

Ubicación del inventario

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Sujeto a disponibilidad

Documentation

Descargar MSDS

Descargar COA de muestra

Incluye: HPLC, MASS/LC-MS, RMN de 1H, FT-IR, potencia, informe de elucidación estructural (SER) y datos analíticos adicionales según el producto.

Tofacitinib Nitrosamine 1

● Under Development

Número de catálogo:VE009892
N.º CAS:N/A
Fórmula mol.::C15H17N7O2
Peso mol.::327.34 g/mol

Información adicional sobre el Tofacitinib Nitrosamine 1

Fármaco de origen

Tofacitinib

Nombre IUPAC

N-(1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-(7H-pyrrolo[2, 3-d]pyrimidin-4-yl)nitrous amide

Sinónimos

N-Nitroso N-desmethyl Tofacitinib

SMILES

O=NN(C1CN(C(CC#N)=O)CCC1C)C2=C3C(NC=C3)=NC=N2

InChI

InChI=1S/C15H17N7O2/c1-10-4-7-21(13(23)2-5-16)8-12(10)22(20-24)15-11-3-6-17-14(11)18-9-19-15/h3,6,9-10,12H,2,4,7-8H2,1H3,(H,17,18,19)

Descripción

Tofacitinib Nitrosamine 1 is an N-nitroso derivative of the secondary amine present in Tofacitinib, which is a highly characterized reference material that meets stringent regulatory standards set for nitrosamine compounds, including those set by USP, EMA, JP, and BP. This nitroso standard is essential for a variety of applications, such as analytical method development, method validation (AMV), and Quality Control (QC), particularly in the context of Tofacitinib production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). This nitrosamine standard helps establish detection limits, quantify impurity levels, and ensure trace nitroso impurities in pharmaceutical products remain within FDA and EMA safety limits.

Solicitar cotización

"*" señala los campos obligatorios

Este campo es un campo de validación y debe quedar sin cambios.
Products quotation
Nombre
Url